tradingkey.logo
tradingkey.logo
Search

Healthcare

LIST1000
1495.365USD
+39.299+2.70%
Close 03/31, 16:00ETQuotes delayed by 15 min
7.18TMarket Cap
1.99BVolume
1456.065Open
1495.641High
1.99BVolume
752Up
264Down
116Unchanged
7.18TMarket Cap
1456.066Prev. Close
1456.065Low
33.23BTurnover

Healthcare

1495.365
+39.299+2.70%

Related Stocks

No.
Name
Price
Change
Chg %
Total Score
Time
Volume
Turnover
Market Cap
Shares
Amplitude
Volume Ratio
52wk High
52wk Low
Dividends
Div Yield
5D
10D
20D
60D
120D
250D
Year to Date
Watchlist
Akari Therapeutics PLC
Akari Therapeutics PLC
AKTX
5.160
+5.034
+3985.51%
3.91
27.52K
122.54K
168.29M
32.61M
701.50
0.11
1.580
0.120
0.00
0.00
+3652.73%
+2288.89%
+2143.48%
+1679.31%
+391.43%
+369.09%
+1685.47%
Modular Medical Inc
Modular Medical Inc
MODD
5.280
+5.123
+3265.20%
4.51
265.46K
1.08M
2.20M
416.61K
1252.39
0.22
1.160
0.118
0.00
0.00
+2984.11%
+2190.67%
+3042.86%
+1271.78%
+688.30%
+388.89%
+1350.15%
agilon health inc
agilon health inc
AGL
7.905
+7.509
+1895.20%
6.05
406.03K
1.26M
3.04B
384.02M
246.08
0.11
6.080
0.304
0.00
0.00
+1708.92%
+1187.46%
+1293.20%
+1073.55%
+645.75%
+93.75%
+1047.81%
4
Fibrobiologics Inc
Fibrobiologics Inc
FBLG
1.315
+1.118
+568.87%
--
7.67M
4.75M
42.71M
32.48M
419.63
46.19
30.600
2.260
0.00
0.00
-74.45%
-76.19%
-83.11%
-72.59%
-86.59%
-92.35%
-70.76%
5
PMGC Holdings Inc
PMGC Holdings Inc
ELAB
5.970
+4.300
+257.49%
3.60
49.73M
144.48M
73.90K
12.38K
178.43
1.56
466.200
1.620
0.00
0.00
+106.57%
+34.46%
-1.49%
-82.48%
-96.08%
-98.36%
-83.19%
6
BullFrog AI Holdings, Inc.
BullFrog AI Holdings, Inc.
BFRG
1.670
+1.162
+228.53%
4.99
194.75M
220.07M
9.47M
5.67M
149.51
2.32
2.200
0.425
0.00
0.00
+196.98%
+166.33%
+192.96%
+89.72%
+12.07%
+1.21%
+89.16%
7
Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals Inc
APLS
40.238
+23.268
+137.11%
7.34
90.33M
2.69B
1.98B
49.26M
1.29
42.48
30.480
16.100
0.00
0.00
+133.53%
+113.80%
+99.59%
+55.60%
+59.61%
+77.42%
+60.18%
8
Centessa Pharmaceuticals PLC
Centessa Pharmaceuticals PLC
CNTA
39.680
+10.980
+38.26%
7.76
47.74M
1.57B
5.33B
134.42M
2.36
25.42
30.580
9.600
0.00
0.00
+42.27%
+37.06%
+51.45%
+67.50%
+71.63%
+199.92%
+58.66%
9
Virax Biolabs Group Ltd
Virax Biolabs Group Ltd
VRAX
0.217
+0.058
+36.35%
0.85
237.12M
27.77M
247.05K
1.14M
49.84
1123.67
1.340
0.152
0.00
0.00
+22.23%
+7.15%
+7.00%
-43.44%
-66.12%
-80.22%
-37.19%
10
SeaStar Medical Holding Corp
SeaStar Medical Holding Corp
ICU
3.710
+0.970
+35.40%
6.37
542.75K
1.38M
1.88M
507.99K
25.11
0.95
17.250
2.070
0.00
0.00
+65.62%
+49.60%
+44.92%
+41.01%
-42.24%
+147.33%
+54.58%

News

Helium’s 2026 Shock: Which Stocks are Most Affected

Most investors don’t spend much time thinking about helium. It’s the party-balloon gas… or at least that’s what most people think. But But behind the scenes, helium keeps a lot of high-end tech running - and supply has tightened fast lately.

TradingKeyFri, Mar 20
Most investors don’t spend much time thinking about helium. It’s the party-balloon gas… or at least that’s what most people think. But But behind the scenes, helium keeps a lot of high-end tech running - and supply has tightened fast lately.

Today’s Market Recap: Markets Edge Up Amid Iran Conflict and Fed Rate Scrutiny

U.S. indices edged higher as investors weighed optimistic tech developments from Nvidia, Amazon, and Micron against a volatile geopolitical backdrop.

TradingKeyWed, Mar 18
U.S. indices edged higher as investors weighed optimistic tech developments from Nvidia, Amazon, and Micron against a volatile geopolitical backdrop.

Today’s Market Recap: Markets Rally as Oil Retreats Amid Tech Breakthroughs and Geopolitical Tensions

US Indices Gain as Oil Supply Fears Ease; Trump Admin Presses Fed Subpoena Case

TradingKeyTue, Mar 17
US Indices Gain as Oil Supply Fears Ease; Trump Admin Presses Fed Subpoena Case

Rhythm Pharma's Drug Fails Key Genetic Obesity Trial, Shares Fall

March 16 (Reuters) - Rhythm Pharmaceuticals RYTM.O said on Monday its experimental obesity drug in patients with rare genetic conditions did not meet the main goal of a late-stage trial.

ReutersTue, Mar 17
March 16 (Reuters) - Rhythm Pharmaceuticals RYTM.O said on Monday its experimental obesity drug in patients with rare genetic conditions did not meet the main goal of a late-stage trial.

What Are Defensive Stocks? Best Defensive Stocks to Buy in 2026

TradingKey - Defensives run on resilience: predictable demand, strong cash flow, conservative balance sheets, and tame volatility. You can’t just look at a sector name to find them. It requires a systematic examination of cash generation, leverage, dividend sustainability, beta, competitive moats, a

TradingKeyMon, Mar 16
TradingKey - Defensives run on resilience: predictable demand, strong cash flow, conservative balance sheets, and tame volatility. You can’t just look at a sector name to find them. It requires a systematic examination of cash generation, leverage, dividend sustainability, beta, competitive moats, a

Hims & Hers Soars 64% in Three Days as Novo Nordisk Deal Opens Door to GLP-1 Market

TradingKey - Shares of Hims & Hers Health (HIMS.US) surged nearly 64% cumulatively over the first three trading days of this week, with an intraday rally of over 10% on Wednesday.

TradingKeyThu, Mar 12
TradingKey - Shares of Hims & Hers Health (HIMS.US) surged nearly 64% cumulatively over the first three trading days of this week, with an intraday rally of over 10% on Wednesday.
KeyAI